Red Light Holland Announces Filament Health Obtains Interim Order for Proposed Arrangement
Toronto, Ontario--(Newsfile Corp. - March 23, 2026) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light" or the "Company") and Filament Health Corp. (OTC: FLHLF) ("Filament") today announced that, further to the joint press release dated March 10, 2026, the Supreme Court of British Columbia issued an interim order (the "Interim Order") in connection with the previously announced acquisition by Red Light of all the issued and outstandin
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2026-03-23 8:15 AM EDT | Red Light Holland Corp.
Psyched Wellness Announces Closing of Private Placement and Shares for Debt Transaction and Resignation of a Director
Toronto, Ontario--(Newsfile Corp. - March 20, 2026) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company"), a life sciences company focused on the production and distribution of Amanita Muscaria-derived health and wellness products, announces the closing of (i) the first tranche of its non-brokered private placement (the "Offering") for gross proceeds of C$859,653.47, led by Gotham Green Fund III, L.P. and Gotham Green Fund III (Q), L.P. (together with the
Cannabis, Health, Psychedelics, Cannabis Manufacturer
2026-03-20 9:16 AM EDT | Psyched Wellness Ltd.
Delivra Health Brands Launches Dream Water(R) Kids Sleep Gummies in the United States Market
Vancouver, British Columbia--(Newsfile Corp. - March 19, 2026) - Delivra Health Brands Inc. (TSXV: DHB) (OTCQB: DHBUF) ("Delivra Health" or the "Company"), a consumer packaged goods company uniquely positioned in the health and wellness sector, is pleased to announce that its Dream Water® brand is launching its new Dream Water Kids Sleep Gummies in the US market. Dream Water Kids Sleep Gummies are expected to be available to Company distributors, retailers and e-c
Cannabis, Health, Cannabis Extractor, Cannabis Manufacturer
2026-03-19 5:30 PM EDT | Delivra Health Brands Inc.
City View Announces Filing of Change of Business Documents with the CSE
Toronto, Ontario--(Newsfile Corp. - March 19, 2026) - City View Green Holdings Inc. (CSE: CVGR) (OTCID: CVGRF) (FSE: CVY0) (the "Company" or "City View") announces that it has filed the necessary Form 2A Listing Statement with the CSE providing full disclosure on the new business model in connection with its proposed change of business from an "industrial issuer" to an "investment issuer" (the "Proposed COB"). In connection with the Proposed COB and subject to CSE approval, the Company inten
Food / Beverages, Cannabis, Cannabis Extractor, Cannabis Manufacturer
2026-03-19 7:00 AM EDT | City View Green Holdings Inc.
Red Light Holland Engages Kala Bio's Researgency.ai Platform to Support Clinical Development of Filament Health's Patented PEX010 Botanical Psilocybin Drug Candidate
Ontario and Arlington, Massachusetts--(Newsfile Corp. - March 18, 2026) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light" or the "Company") and Kala Bio, Inc. (NASDAQ: KALA) ("Kala Bio") today announced that Red Li
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2026-03-18 8:15 AM EDT | Red Light Holland Corp.
PharmaCielo Announces the Issuance of Interest Shares
Ontario and Rionegro, Colombia--(Newsfile Corp. - March 17, 2026) - PharmaCielo Ltd. (TSXV: PCLO) (OTC Pink: PCLOF) ("PharmaCielo" or the "Company"), the Canadian parent of Colombia's premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S., today announced that, as approved by the TSX
2026-03-17 7:30 AM EDT | PharmaCielo Ltd.
Digicann Ventures Announces Agreement to Extend Maturity Date for Convertible Debentures
Vancouver, British Columbia--(Newsfile Corp. - March 12, 2026) - Digicann Ventures Ltd. (CSE: DCNN.X) ("Digicann" or the "Company"), a company focused on opportunities within and outside of the cannabis industry, announces that it has entered into an agreement with holders of the Company's 10.00% Senior Unsecured Convertible Debentures (the "Debentures") to amend the Debentures to extend the maturity date for an additional twelve months from March 12, 2026 to March 12, 2027.
Banking / Financial Services, Cannabis
2026-03-12 5:01 PM EDT | Digicann Ventures Inc.
Psyched Wellness Announces Private Placement for Proceeds of up to C$1,719,306.94
Toronto, Ontario--(Newsfile Corp. - March 11, 2026) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched Wellness"), a life sciences company focused on the production and distribution of health and wellness products derived from the Amanita Muscaria mushroom, is excited to announce that it has entered into a non-binding memorandum of terms (the "Term Sheet") with Gotham Green Fund III, L.P. and Gotham Green Fund III (Q), L.P. (together,
Cannabis, Health, Psychedelics, Cannabis Manufacturer
2026-03-11 8:54 AM EDT | Psyched Wellness Ltd.
RETRANSMISSION: Red Light Holland Signs Definitive Agreement with Filament Health to Expand Its Platform for Natural Psychedelic Drug Development and Microdosing Innovation
Expands Red Light's drug development platform with Filament's GMP manufacturing, Health Canada Dealer's Licence, Health Canada and FDA-authorized clinical programs, and 76 issued patents covering natural psilocybin manufacturing and formulation Combines Red Light's operational scale, global brand presence, and real-world microdosing data with Filament's pharmaceutical R&D capabilities and patented PEX010 botanical psilocybin drug candidate All-share t
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2026-03-11 7:30 AM EDT | Red Light Holland Corp.
Red Light Holland Signs Definitive Agreement with Filament Health to Expand Its Platform for Natural Psychedelic Drug Development and Microdosing Innovation
Expands Red Light's drug development platform with Filament's GMP manufacturing, Health Canada Dealer's Licence, Health Canada and FDA-authorized clinical programs, and 76 issued patents covering natural psilocybin manufacturing and formulation Combines Red Light's operational scale, global brand presence, and real-world microdosing data with Filament's pharmaceutical R&D capabilities and patented PEX010 botanical psilocybin drug candidate All-share t
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2026-03-10 4:40 PM EDT | Red Light Holland Corp.
Stock Trend Capital Provides Younet AI Investment Update
Vancouver, British Columbia--(Newsfile Corp. - March 9, 2026) - Stock Trend Capital Inc. (CSE: STCQ) (FSE: P0G) (OTC Pink: STOCF) (the "Company" or "Stock Trend") is pleased to provide shareholders with an update regarding its investment in Younet AI ("Younet"), a privately held Canadian company developing artificial-intelligence platforms and tools enabling users to build customized AI models trained on their own data to automate tasks, e
Technology, Internet Technology, Cannabis
2026-03-09 6:20 AM EDT | Stock Trend Capital Inc.
Vext Advances Ohio Expansion with Seventh Retail Location
Secures provisional dual-use license for Columbus dispensary, with operations expected to begin in Q4 2026, subject to regulatory approvals. Marks Vext's seventh dispensary in Ohio, and second in Columbus, as the Company advances toward the state's eight-store cap. Scales vertically integrated footprint in Ohio, positioning Vext to drive operating leverage and cash flow growth as additional retail locations come online and s
Cannabis, Cannabis Cultivator, Cannabis Dispensary, Cannabis Manufacturer
2026-03-03 5:00 PM EST | VEXT Science, Inc.
Nextleaf Solutions Reports Profitable Q1 FY26 with Revenue Growth and Positive Operating Cash Flow
Vancouver, British Columbia--(Newsfile Corp. - March 3, 2026) - Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (FSE: L0MA) ("Nextleaf", "OILS", or the "Company"), a multi-patented life science company and Canadian cannabis processor announced today its financial results for the three months ended December 31, 2025 ("Q1 FY26") reporting gross revenue of CAD $3,994,369, net revenue of CAD $3,020,519, and gross profit of CAD $1,288,197. Q1 FY26 marked continued execution, with s
Biotechnology, Pharmaceuticals, Cannabis, Cannabis Extractor
2026-03-03 8:59 AM EST | Nextleaf Solutions Ltd.
Red Light Holland Reports Third Quarter 2026 Results and Provides Corporate Update
Toronto, Ontario--(Newsfile Corp. - March 3, 2026) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland" or the "Company"), an Ontario-based organization advancing a focused strategy within the legal psychedelic sector, centered on consensual data collection and research and development ("R&D") initiatives designed to expand naturally occurring drug development, understanding of psilocybin use and consumer experie
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2026-03-03 8:00 AM EST | Red Light Holland Corp.
Delota Reports Financial Results for the Three and Nine Months Ended December 31, 2025
Highlights Total revenue of $8.4 million for Q3 2026 Total System-Wide Revenue of $10.0 million for Q3 2026 30% gross profit margin for Q3 2026 Total revenue of $27.1 million for the Nine Months Ended 2026 Total System-Wide Revenue of $30.9 million for the Nine Months Ended 2026 33% gross profit margin for the Nine Months Ended 2026
Retail, Cannabis, Health, Cannabis Dispensary
2026-03-03 7:30 AM EST | Delota Corp.
Adastra Holdings Announces Agreement to Sell Assets and Resignation of Director
Langley, British Columbia--(Newsfile Corp. - March 2, 2026) - Adastra Holdings Ltd. (CSE: XTRX) (FSE: D2E0) ("Adastra" or the "Company") announces that Adastra Labs Inc. ("Adastra Labs"), a wholly-owned subsidiary of the Company, has entered into an asset purchase agreement dated February 27, 2026 with an arm's length purchaser (the "Purchaser"), pursuant to which Adastra Labs has agreed to sell certain cryoethanol and hydrocarbon extraction and process
2026-03-02 8:30 AM EST | Adastra Holdings Ltd.
Simply Solventless Announces Endorsement and Support of Restructuring Plan from Secured Debt Holders
Calgary, Alberta--(Newsfile Corp. - March 2, 2026) - Simply Solventless Concentrates Ltd. (TSXV: HASH) ("SSC") announces that Plaza Capital ("Plaza"), SSC's largest secured convertible debenture ("CD") holder, and Altek Acquisition Partnership ("AAP"), SSC's largest promissory note ("PN") holder (and one of SSC's largest shareho
Cannabis, Cannabis Cultivator, Cannabis Extractor, Cannabis Manufacturer
2026-03-02 8:00 AM EST | Simply Solventless Concentrates Ltd.
PharmaCielo Announces 2025 Q3 Results, AGM Details
Ontario and Rionegro, Colombia--(Newsfile Corp. - March 2, 2026) - PharmaCielo Ltd. (TSXV: PCLO) (OTC Pink: PCLOF) ("PharmaCielo" or the "Company"), the Canadian parent of Colombia's premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S., today announced results of the quarter ended Decem
2026-03-02 7:30 AM EST | PharmaCielo Ltd.
Delivra Health and Its Brands LivRelief (TM) and Dream Water (TM) Report Results for Second Quarter of Fiscal 2026
Vancouver, British Columbia--(Newsfile Corp. - February 27, 2026) - Delivra Health Brands Inc. (TSXV: DH
Cannabis, Health, Cannabis Extractor, Cannabis Manufacturer
2026-02-27 6:45 PM EST | Delivra Health Brands Inc.
Simply Solventless Commences Restructuring Process for the Benefit of Shareholders and Stakeholders
Calgary, Alberta--(Newsfile Corp. - February 27, 2026) - Simply Solventless Concentrates Ltd. (TSXV: HASH) ("SSC") announces that it has commenced a restructuring process for the benefit of SSC's shareholders and stakeholders (the "Restructuring"). The Restructuring is intended to maximize value and balance sheet strength for shareholders, creditors, and other stakeholders (the "Stakeholders"). It is expected that SSC's common shares will continue to trade on the
Cannabis, Cannabis Cultivator, Cannabis Extractor, Cannabis Manufacturer
2026-02-27 5:05 PM EST | Simply Solventless Concentrates Ltd.